Site actif de la glucocérébrosidase humaine : prédictions structurales et validations expérimentales
J. Soc. Biol., 196 2 (2002) 151-160
Publié en ligne : 2017-04-04
Article cité par
La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).
Article cité :
Citations de cet article :
Bio-loggers and miRNAs are innovative tools for measuring physiological changes in lambs during transport
Isabella Manenti, Irene Viola, Francisco Canto, Paolo Accornero, Paola Toschi, Carmine Versace, Elisabetta Macchi, Eugenio Martignani, José Alfonso Abecia and Silvia MirettiJournal of Animal Science 103 (2025)
https://doi.org/10.1093/jas/skaf123
In situ fluorescence imaging reveals that mitochondrial H2O2 mediates lysosomal dysfunction in depression
Xin Wang, Qi Ding, Ying Tian, et al.Chemical Communications 58 (43) 6320 (2022)
https://doi.org/10.1039/D2CC00431C
N-Glycosylation and Gaucher Disease Mutation Allosterically Alter Active-Site Dynamics of Acid-β-Glucosidase
Michael Gregory Souffrant, Xin-Qiu Yao, Mohamed Momin and Donald HamelbergACS Catalysis 10 (3) 1810 (2020)
https://doi.org/10.1021/acscatal.9b04404
Insights into the structural biology of Gaucher disease
Laura Smith, Stephen Mullin and Anthony H.V. SchapiraExperimental Neurology 298 180 (2017)
https://doi.org/10.1016/j.expneurol.2017.09.010
Glucosylceramidases and malignancies in mammals
Leonardo Astudillo, Nicole Therville, Céline Colacios, et al.Biochimie 125 267 (2016)
https://doi.org/10.1016/j.biochi.2015.11.009
Mass spectrometric study of gas‐phase ions of acid β‐glucosidase (Cerezyme) and iminosugar pharmacological chaperones
Khadijeh RajabiJournal of Mass Spectrometry 49 (10) 1002 (2014)
https://doi.org/10.1002/jms.3412
Gaucher Disease: Basic and Clinical Perspectives
Marc N Offman, Israel Silman, Joel L Sussman and Anthony H FutermanGaucher Disease: Basic and Clinical Perspectives 124 (2013)
https://doi.org/10.2217/ebo.12.215
The pathophysiology of GD – current understanding and rationale for existing and emerging therapeutic approaches
Derralynn A. Hughes and Gregory M. PastoresWiener Medizinische Wochenschrift 160 (23-24) 594 (2010)
https://doi.org/10.1007/s10354-010-0864-4
Acid β-glucosidase: insights from structural analysis and relevance to Gaucher disease therapy
Yaacov Kacher, Boris Brumshtein, Swetlana Boldin-Adamsky, et al.bchm 389 (11) 1361 (2008)
https://doi.org/10.1515/BC.2008.163
The studies on substrate, product and inhibitor binding to a wild-type and neuronopathic form of human acid-β-glucosidase
Igor Z. Zubrzycki, Agnieszka Borcz, Magdalena Wiacek and Wojciech HagnerJournal of Molecular Modeling 13 (11) 1133 (2007)
https://doi.org/10.1007/s00894-007-0232-5
Synthesis of 4-O-glycosylated 1-deoxynojirimycin derivatives as disaccharide mimics-based inhibitors of human β-glucocerebrosidase
Charlotte Boucheron, Sylvestre Toumieux, Philippe Compain, et al.Carbohydrate Research 342 (12-13) 1960 (2007)
https://doi.org/10.1016/j.carres.2007.03.015
Rational Design and Synthesis of Highly Potent β‐Glucocerebrosidase Inhibitors
Xiaoxiang Zhu, Kamlesh A. Sheth, Shihong Li, Hui‐Hwa Chang and Jian‐Qiang FanAngewandte Chemie International Edition 44 (45) 7450 (2005)
https://doi.org/10.1002/anie.200502662
Rational Design and Synthesis of Highly Potent β‐Glucocerebrosidase Inhibitors
Xiaoxiang Zhu, Kamlesh A. Sheth, Shihong Li, Hui‐Hwa Chang and Jian‐Qiang FanAngewandte Chemie 117 (45) 7616 (2005)
https://doi.org/10.1002/ange.200502662
X‐ray structure of human acid‐β‐glucosidase, the defective enzyme in Gaucher disease
Hay Dvir, Michal Harel, Andrew A McCarthy, Lilly Toker, Israel Silman, Anthony H Futerman and Joel L SussmanEMBO reports 4 (7) 704 (2003)
https://doi.org/10.1038/sj.embor.embor873